Advancing Chemistry, Enhancing Health

Our proprietary platform enables us to develop safer and more effective active ingredients for next-generation medical products and treatments. Our disruptive patented compounds are licensed
by pharmaceutical companies worldwide.

TSX-V: SBM
FSE: ZSB | OTC: SRBCF
Howard J. Verrico, MD
Founder, Sirona Biochem
CEO and Chairman of the Board

Welcome to Sirona Biochem

Sirona Biochem’s strategy is to license or sell patented compounds to leading global companies in return for up-front fees, milestone fees and ongoing royalty payments.

divider
I'm delighted to announce that Sirona Biochem has signed a global exclusive licensing agreement with Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, for TFC-1067.
divider
Go In-Depth

Our Investor's Presentation provides a clear overview of Sirona Biochem, its operations, technology and other information relevant to prospective investors.



TSX-V: SMB

TSX Venture Exchange

FSE: ZSB

Frankfurt Stock Exchange

OTC: SRBCF

OTCQB Exchange

About Sirona Biochem

Sirona Biochem is a cosmetic ingredient and drug discovery firm with a proprietary technology. Through its wholly-owned French Subsidary TFChem, the Company specialises in stabilising carbohydrate moleclues with the goal of improving efficiacy and safety.

divider
Our world class team is comprised of award winning scientists who have worked for Fortune 500 companies such as Sanofi, GSK and Bayer.
divider
Geraldine Deliencourt-Godefroy, PhD
Founder TFChem
Chief Scientific Officer

Our Proprietary Technology

Sirona's Flourination Chemistry Technology is the solution to unstable carbohydrate molecules.

The chemistry strengthens the bond of a carbohydrate molecule by strategically placing flourine atoms.

Our technology has received more than $8M CAD in grants from the French Government

Sirona has 83 approved and pending patents globally.

Carbohydrate molecules are unstable by nature

Sirona’s Technology stabilizes carbohydrate molecule

Our Pipeline

Cosmetic Products
TFC-1067
Dark Spot Corrector
TFC-1326
Anti-Aging
(TBA)
Cellulite Treatment
Pharmaceutical Products
TFC-039
Animal Health
Anti-Viral

Sirona Biochem has invested extensively in developing its products to meet the needs of patients and industry partners.

The compounds created through our proprietary platform go through rigorous tests and regulatory scrutiny to verify their safety and efficacy.

Sirona Biochem is traded on:

TSX-V: SBM
FSE: ZSB
OTC: SRBCF

Our Partners

AbbVie
Wanbang Biopharmaceuticals
WuXi AppTec
Polepharma
Insitut National des sciences appliquees de Rouen